uspto-grants-2010_06 · 10.6084/m9.figshare.5104873.v1 · US07737266B2
查看HCID66584655
3({6-[17-(1,5-Dimethyl-hexyl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yloxycarbonylamino]-hexanoyl}ethoxycarbonylmethyl-amino)-propionic acid ethyl ester
ethyl 3-[6-[[10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxycarbonylamino]hexanoyl-(2-ethoxy-2-oxoethyl)amino]propanoate
C43H72N2O7729 g/mol
IDENTITY
结构与身份
- 标准SMILES
- CCOC(=O)CCN(CC(=O)OCC)C(=O)CCCCCNC(=O)OC1CCC2(C)C(=CCC3C2CCC2(C)C(C(C)CCCC(C)C)CCC32)C1
- InChIKey
- PHAADKIAVZTTNS-UHFFFAOYSA-N
- 分子式
- C43H72N2O7
- 平均分子量
- 729 g/mol
- 单同位素质量
- 728.53395264
COMPUTED
结构计算性质
- XLogP
- 9.9
- 极性表面积
- 111 Ų
- 氢键供体
- 1
- 氢键受体
- 7
- 可旋转键
- 22
- 重原子
- 52
- 形式电荷
- 0
- 复杂度
- 1,230
物化、安全与法规信息正在同步。
ALIASES
名称与别名
SCHEMBL29929PHAADKIAVZTTNS-UHFFFAOYSA-N3({6-[17-(1,5-Dimethyl-hexyl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yloxycarbonylamino]-hexanoyl}ethoxycarbonylmethyl-amino)-propionic acid ethyl ester3-({6-[17-(1,5-D imethyl-hexyl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yloxycarbonylamino]-hexanoyl}ethoxycarbonylmethyl-amino)-propionic acid ethyl ester3-({6-[17-(1,5-Dimethyl-hexyl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro 1H-cyclopenta[a]phenanthren-3-yloxycarbonylamino]-hexanoyl}ethoxycarbonylmethyl-amino)-propionic acid ethyl ester3-({6-[17-(1,5-dimethyl-hexyl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-3 -yloxycarbonylamino]-hexanoyl}ethoxycarbonylmethyl-amino)-propionic acid ethyl ester3-({6-[17-(1,5-dimethyl-hexyl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-3-yl oxycarbonyl amino]-hexanoyl}ethoxycarbonylmethyl-amino)-propionic acid ethyl ester3-({6-[17-(1,5-Dimethyl-hexyl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yloxycarbonylamino]-hexanoyl }ethoxycarbonylmethyl-amino)-propionic acid ethyl ester3-({6-[17-(1,5-dimethyl-hexyl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-3-yloxycarbonylamino]-hexanoyl}-ethoxycarbonylmethyl-amino)-propionic acid ethyl ester3-({6-[17-(1,5-Dimethyl-hexyl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yloxycarbonylamino]-hexanoyl}ethoxy-carbonylmethyl-amino)-propionic acid ethyl ester3-({6-[17-(1,5-dimethyl-hexyl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-3-yloxycarbonylamino]-hexanoyl}ethoxycarbonylmethyl-amino)-propionic acid ethyl ester3-({6-[17-(1,5-Dimethyl-hexyl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[alpha]phenanthren-3-yloxycarbonylamino]-hexanoyl}ethoxycarbonylmethyl-amino)-propionic acid ethyl ester3-({6-[17-(1,5-dimethylhexyl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-3-yloxycarbonylamino]-hexanoyl}ethoxycarbonylmethyl-amino)-propionic acid ethyl ester
REACTIONS
参与反应
uspto-grants-2010_06 · 10.6084/m9.figshare.5104873.v1 · US07745608B2
查看uspto-grants-2008_09 · 10.6084/m9.figshare.5104873.v1 · US07423142B2
查看uspto-grants-2016_09 · 10.6084/m9.figshare.5104873.v1 · US09441225B2
查看uspto-grants-2014_02 · 10.6084/m9.figshare.5104873.v1 · US08658782B2
查看uspto-grants-2011_01 · 10.6084/m9.figshare.5104873.v1 · US07868160B2
查看uspto-grants-2011_01 · 10.6084/m9.figshare.5104873.v1 · US07871985B2
查看uspto-grants-2011_01 · 10.6084/m9.figshare.5104873.v1 · US07875711B2
查看